The risk for thyroid cancer over a maximum of 8 years of follow-up did not differ between GLP-1 medication users and adults using an SGLT2 inhibitor, DPP-IV inhibitor or sulfonylurea, though GLP-1 users did have a higher thyroid cancer risk during the first year of therapy
GLP-1 medications like Ozempic and Wegovy are changing how people approach weight management
BPC-157 activates vascular endothelial growth factor receptor 2 (VEGFR2), which triggers nitric oxide synthesis through the Akt-eNOS axis
The broader federal GLP-1 MDL, which includes gastrointestinal and other alleged injuries, now exceeds 3,000 pending cases, reflecting continued growth across multiple injury categories
Reducing visceral fat improves metabolic health, insulin sensitivity, and overall energy levels
doi: 10.1126/scisignal.adx6752, 211 WadhwaS.JainS.PatilN.JungadeS